An expert panel of India’s drug regulator on Friday sought additional data from drugmaker Dr. Reddy’s Laboratories on its Sputnik V Covid-19 vaccine trial, in its second such request after an initial evaluation in February.
Dr. Reddy’s has been conducting small clinical trials with Sputnik V in India under a deal with Russia’s wealth fund. Several Indian companies have signed deals to produce and supply over a half a billion doses of the vaccine.
The Committee asked the company to submit a comparative analysis of late-stage immunogenicity data from both its Indian studies and an ongoing Russian study, as well as data on serious adverse events and positive cases reported till date.
Source: Reuters
Throughout history, the pomegranate has been a revered fruit, not only for its vibrant appearance…
Secrets of Essential Nutrients: How Vitamins, Proteins, and Fats Boost Your Health and Keep Your…
Air Pollution Awareness: Did you know that rising air pollution can have a serious impact…
Obesity vs Diabetes: In this video, we discuss the strong connection between obesity and diabetes.…
5 Foods to Naturally Increase Collagen Production Collagen is one of the most abundant proteins…
Heart Attack Symptom: THIS Sign in Your Mouth Can Help in Early Detection Heart disease…